In a groundbreaking pooled analysis published in the British Journal of Cancer, researchers from the German AIO Study Group have elucidated the complex interplay between steroid and antibiotic treatments and their impact on the efficacy of cancer immunotherapy. This extensive study synthesizes data from seven pivotal clinical trials—RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC, and TITAN-TCC—offering unprecedented insight into how timing o…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.